Latest Insider Transactions at Celularity Inc (CELU)
This section provides a real-time view of insider transactions for Celularity Inc (CELU). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Celularity Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Celularity Inc's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 13
2022
|
Dean C Kehler Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
Jul 13
2022
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,124
+28.57%
|
-
|
Jul 13
2022
|
Marc Mazur Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
Jul 13
2022
|
Diane L. Parks Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
Jul 13
2022
|
Anne Jones Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,483
+29.17%
|
-
|
Jul 13
2022
|
Kyle Fletcher Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,297
+6.09%
|
-
|
Jul 13
2022
|
Robin L Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
Jul 13
2022
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+20.98%
|
-
|
Apr 13
2022
|
Anne Jones Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,405
+50.0%
|
-
|
Apr 13
2022
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,686
+50.0%
|
-
|
Apr 13
2022
|
David C Beers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,011
+50.0%
|
-
|
Apr 13
2022
|
Stephen Brigido Pres, Functional Regeneration |
BUY
Grant, award, or other acquisition
|
Direct |
32,809
+50.0%
|
-
|
Apr 13
2022
|
Keary Dunn Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,405
+50.0%
|
-
|
Apr 13
2022
|
Robert J Hariri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
131,234
+1.64%
|
-
|
Apr 13
2022
|
John R Haines Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,617
+50.0%
|
-
|
Mar 01
2022
|
Starr International CO Inc > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
6,640,694
+30.29%
|
$19,922,082
$3.5 P/Share
|
Nov 16
2021
|
Bradley Glover Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,734
-6.46%
|
$3,734
$1.89 P/Share
|
Nov 16
2021
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+30.19%
|
-
|
Nov 16
2021
|
Anne Jones Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+32.1%
|
-
|
Nov 09
2021
|
Andrew C. Von Eschenbach Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$0
$0.28 P/Share
|
Jul 16
2021
|
Kok Thay Lim |
BUY
Grant, award, or other acquisition
|
Indirect |
30,062,778
+30.21%
|
$300,627,780
$10.0 P/Share
|
Jul 16
2021
|
Robert J Hariri Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
7,734,689
+50.0%
|
-
|
Jul 16
2021
|
Dean C Kehler Director |
SELL
Other acquisition or disposition
|
Indirect |
7,087,500
-98.61%
|
-
|
Jul 16
2021
|
Dean C Kehler Director |
BUY
Conversion of derivative security
|
Indirect |
7,187,500
+50.0%
|
-
|
Jul 16
2021
|
Gx Sponsor LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
7,087,500
-98.61%
|
-
|
Jul 16
2021
|
Gx Sponsor LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
7,187,500
+50.0%
|
-
|
Jul 16
2021
|
Jay R Bloom Director |
SELL
Other acquisition or disposition
|
Indirect |
7,087,500
-98.61%
|
-
|
Jul 16
2021
|
Jay R Bloom Director |
BUY
Conversion of derivative security
|
Indirect |
7,187,500
+50.0%
|
-
|